×

Main navigation

Skip links

FDA Detention Testing & Sampling

Accelerate removal from the FDA Red List through comprehensive sampling, testing, and oversight.

AGQ Labs’ FDA detention management empowers businesses to gauge product compliance and safety, ensuring adherence to regulatory standards. With precise risk evaluation, we help firms identify and address potential issues early, securing a clear path to meet and surpass FDA requirements.

FDA Testing
Testing & Sampling
Only Sampling

What are FDA Detentions?

The U.S. government’s Food and Drug Administration (FDA) ensures that all products imported into the United States meet regulatory standards and are safe for U.S. consumers. If a product imported into the U.S. is found adulterated, misbranded, or disapproved for entry, the FDA will detain it by preventing its release (Detentions).

What steps should you take following a Notice of Action?

Importer notified of detention (FDA Notice of Action)

 

The FDA maintains strict control over products imported into the United States. If there is any suspicion, it can stop a product from entering the market and place the company on a “red list.”

Acting quickly to provide the FDA with analytical reports demonstrating the product’s conformity is vital.

 

At AGQ Labs, we have the experience, technology, and accreditation necessary to respond to the FDA quickly and effectively.

Thank you for contacting AGQ Labs.

We kindly request the following documents to ensure a smooth and efficient sampling process.

 

Required Documents:

  • Notice of Action (NOA): This document from the FDA details the specific entry and product information.
  • Invoices: Commercial invoices for the shipment.
  • Bill of Lading (BOL): A document issued by the carrier that serves as a receipt for the goods and details the shipment information.
  • Packing List: An itemized list of the contents in the shipment.

Additional Information:

  • Warehouse Address: The physical location where the samples will be collected.
  • Warehouse Contact Name and Phone Number: The designated person at the warehouse to coordinate the sampling visit.
  •  

By providing this information upfront, we can expedite the scheduling and coordination of the sampling process and minimize any potential delays.

AGQ Labs performs sampling or contacts a sampling partner to do it.

Samples are transported to AGQ Labs.

Samples are received, registered, and processed for analysis.

FDA-specific package submission via ITACS.

FDA reviews AGQ Labs analytical package.

Compliance – products cleared for market distribution.

Importer notified of detention (FDA Notice of Action)

 

The FDA maintains strict control over products imported into the United States. If there is any suspicion, it can stop a product from entering the market and place the company on a “red list.”

Acting quickly to provide the FDA with analytical reports demonstrating the product’s conformity is vital.

 

At AGQ Labs, we have the experience, technology, and accreditation necessary to respond to the FDA quickly and effectively.

Thank you for contacting AGQ Labs.

We kindly request the following documents to ensure a smooth and efficient sampling process.

 

Required Documents:

  • Notice of Action (NOA): This document from the FDA details the specific entry and product information.
  • Invoices: Commercial invoices for the shipment.
  • Bill of Lading (BOL): A document issued by the carrier that serves as a receipt for the goods and details the shipment information.
  • Packing List: An itemized list of the contents in the shipment.

Additional Information:

  • Warehouse Address: The physical location where the samples will be collected.
  • Warehouse Contact Name and Phone Number: The designated person at the warehouse to coordinate the sampling visit.
  •  

By providing this information upfront, we can expedite the scheduling and coordination of the sampling process and minimize any potential delays.

AGQ Labs performs sampling or contacts a sampling partner to do it.

Samples are transported to AGQ Labs.

Samples are received, registered, and processed for analysis.

FDA-specific package submission via ITACS.

FDA reviews AGQ Labs analytical package.

Compliance – products cleared for market distribution.

FDA Detention Testing Benefits

Fast Turnaround Time

FDA Compliant Sampling

Real Time Sample Status

550+ Active Compounds

Final Report & Submission

ISO 17025 Accredited Testing

Edit Template

What are FDA Detentions?

The U.S. government’s Food and Drug Administration (FDA) ensures that all products imported into the United States meet regulatory standards and are safe for U.S. consumers. If a product imported into the U.S. is found adulterated, misbranded, or disapproved for entry, the FDA will detain it by preventing its release (Detentions).

What steps should you take to sample your Red List Product?

Importer notified of detention (FDA Notice of Action)

 

The FDA maintains strict control over products imported into the United States. If there is any suspicion, it can stop a product from entering the market and place the company on a “red list.”

Acting quickly to provide the FDA with analytical reports demonstrating the product’s conformity is vital.

 

At AGQ Labs, we have the experience, technology, and accreditation necessary to respond to the FDA quickly and effectively.

Thank you for contacting AGQ Labs.

We kindly request the following documents to ensure a smooth and efficient sampling process.

Required Documents:

  • Notice of Action (NOA): This document from the FDA details the specific entry and product information.
  • Invoices: Commercial invoices for the shipment.
  • Bill of Lading (BOL): A document issued by the carrier that serves as a receipt for the goods and details the shipment information.
  • Packing List: An itemized list of the contents in the shipment.

Additional Information:

  • Warehouse Address: The physical location where the samples will be collected.
  • Warehouse Contact Name and Phone Number: The designated person at the warehouse to coordinate the sampling visit.

 

By providing this information upfront, we can expedite the scheduling and coordination of the sampling process and minimize any potential delays.

AGQ Labs performs sampling or contacts a sampling partner to sample.

Samples are transported to the lab of your choosing.

Importer notified of detention (FDA Notice of Action)

 

The FDA maintains strict control over products imported into the United States. If there is any suspicion, it can stop a product from entering the market and place the company on a “red list.”

Acting quickly to provide the FDA with analytical reports demonstrating the product’s conformity is vital.

 

At AGQ Labs, we have the experience, technology, and accreditation necessary to respond to the FDA quickly and effectively.

Thank you for contacting AGQ Labs.

We kindly request the following documents to ensure a smooth and efficient sampling process.

 

Required Documents:

  • Notice of Action (NOA): This document from the FDA details the specific entry and product information.
  • Invoices: Commercial invoices for the shipment.
  • Bill of Lading (BOL): A document issued by the carrier that serves as a receipt for the goods and details the shipment information.
  • Packing List: An itemized list of the contents in the shipment.

Additional Information:

  • Warehouse Address: The physical location where the samples will be collected.
  • Warehouse Contact Name and Phone Number: The designated person at the warehouse to coordinate the sampling visit.
  •  

By providing this information upfront, we can expedite the scheduling and coordination of the sampling process and minimize any potential delays.

AGQ Labs performs sampling or contacts a sampling partner to do it.

Samples are transported to AGQ Labs.

FDA Detention Sampling
Benefits

Fast Turnaround Time

FDA Compliant Sampling

Real Time Sample Status

Edit Template

Are You Ready To Start

Testing with AGQ Labs?

Questions? Need testing advice?

Contact the experts at AGQ Labs

Skip to content